Assignee
PHARMAGENESIS INC
US·20 granted patents·3 pending applications·452 citations·filing 1993–2015
Top patents by PatentIndex Score
23 records- 0191US7417069B2Halogenated triptolide derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2005·Granted Aug 26, 2008·14 cites·3 claims
- 0291US7098348B2Triptolide derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2006·Granted Aug 29, 2006·16 cites·2 claims
- 0390US6548537B1Triptolide prodrugs having high aqueous solubilityPHARMAGENESIS INC·Filed 2001·Granted Apr 15, 2003·29 cites·13 claims
- 0486US6569893B2Amino acid derivatives of triptolide compounds as immune modulators and anticancer agentsPHARMAGENESIS INC·Filed 2002·Granted May 27, 2003·27 cites·15 claims
- 0586US5648376AImmunosuppressant diterpene compoundPHARMAGENESIS INC·Filed 1995·Granted Jul 15, 1997·46 cites·11 claims
- 0685US7662976B2Triptolide derivatives for modulation of apoptosis and immunosuppressionPHARMAGENESIS INC·Filed 2009·Granted Feb 16, 2010·6 cites·12 claims
- 0784US7019151B2Triptolide derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2003·Granted Mar 28, 2006·15 cites·8 claims
- 0884US6943259B2Halogenated triptolide derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2004·Granted Sep 13, 2005·15 cites·9 claims
- 0983US5843452AImmunotherapy composition and methodPHARMAGENESIS INC·Filed 1994·Granted Dec 1, 1998·83 cites·7 claims
- 1080US5468772ATripterinin compound and methodPHARMAGENESIS INC·Filed 1993·Granted Nov 21, 1995·34 cites·7 claims
- 1177US6150539ATriptolide prodrugs having high aqueous solubilityPHARMAGENESIS INC·Filed 1999·Granted Nov 21, 2000·38 cites·8 claims
- 1276US7863464B2Triptolide lactone ring derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2005·Granted Jan 4, 2011·2 cites·7 claims
- 1373US5663335AImmunosuppressive compounds and methodsPHARMAGENESIS INC·Filed 1996·Granted Sep 2, 1997·34 cites·19 claims
- 1471US5962516AImmunosuppressive compounds and methodsPHARMAGENESIS INC·Filed 1997·Granted Oct 5, 1999·40 cites·11 claims
- 1568US7847109B2Triptolide derivatives for modulation of apoptosis and immunosuppressionPHARMAGENESIS INC·Filed 2003·Granted Dec 7, 2010·2 cites·6 claims
- 1664US6991817B2Acid-modified arabinogalactan protein compositionPHARMAGENESIS INC·Filed 2001·Granted Jan 31, 2006·4 cites·24 claims
- 1764US5759550AMethod for suppressing xenograft rejectionPHARMAGENESIS INC·Filed 1995·Granted Jun 2, 1998·29 cites·10 claims
- 1862US6103875AAntifungal compounds from pseudomonas viridiflavaPHARMAGENESIS INC·Filed 1997·Granted Aug 15, 2000·18 cites·14 claims
- 1950US2007244080A1Method for Treatment of Inflammatory Disorders Using Triptolide CompoundsPHARMAGENESIS INC·Filed 2005·Application pending·0 cites
- 2049US7820834B2Triptolide 5,6-derivatives as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2004·Granted Oct 26, 2010·0 cites·5 claims
- 2146US8048914B2Methods for isolation of triptolide compounds from Tripterygium wilfordiiPHARMAGENESIS INC·Filed 2005·Granted Nov 1, 2011·0 cites·17 claims
- 2238US2016038454A1Intravenous formulations of triptolide compounds as immunomodulators and anticancer agentsPHARMAGENESIS INC·Filed 2014·Application pending·0 cites
- 2332US2017232035A1Polygalacturonan Rhamnogalacturonan1 (PGRG1) CompositionPHARMAGENESIS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →